LUND, Sweden, June 13, 2025 /PRNewswire/ -- To reinforce the importance of energy efficiency in industrial advancement and sustainable progress, Alfa Laval CEO and...
STOCKHOLM, June 13, 2025 /PRNewswire/ -- BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) announced today that the interim safety review of the clinical Phase...
Comprehensive safety studies confirm that ship-to-ship ammonia transfer at anchorage can be both safe and practicableThorough planning, infrastructure readiness, vessel compatibility and clear communications...
TORONTO, June 12, 2025 (GLOBE NEWSWIRE) -- Martinrea International Inc. (“Martinrea” or the “Company”) (TSX : MRE), a diversified and global automotive supplier engaged in the design, development and manufacturing of highly engineered, value-added Lightweight Structures and Propulsion Systems, today announced the results of the election of directors at its annual general meeting.
HONG KONG, June 12, 2025 /PRNewswire/ -- As mobile esports continues its meteoric rise—with global audiences projected to reach 641 million by the end of...
RICHMOND, Texas, June 12, 2025 /PRNewswire/ -- Beatbot, a global leader in cutting-edge robotic pool cleaning technology, announced today that its innovative pool cleaning robots...
NEW YORK, June 11, 2025 /PRNewswire/ -- Space2Sea Alumni—actor William Shatner and astrophysicist Neil deGrasse Tyson— delivered an electrifying and wonderfully chaotic appearance on The...
Next-generation flight deck brings the latest industry-leading innovations to Part 25 transport aircraft
OLATHE, Kan., June 11, 2025 /PRNewswire/ -- Garmin (NYSE: GRMN) today...
MaxCyte and Ori Biotech successfully integrate their ExPERT™ and IRO® platforms to improve the yield of gene-edited T cells and shorten manufacturing timelines
MaxCyte and Ori Biotech successfully integrate their ExPERT™ and IRO® platforms to improve the yield of gene-edited T cells and shorten manufacturing timelines
MINNEAPOLIS, June 10, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a commercial-stage medical device company dedicated to transforming care for fluid overload patients, today announced the closing of a public offering of 2,580,667 shares of its common stock (“Common Stock”), pre-funded warrants to purchase 14,085,998 shares of Common Stock, in each case with accompanying Series A Warrants to purchase up to 49,999,995 shares of Common Stock and Series B Warrants to purchase up to 16,666,665 shares of Common Stock with gross proceeds of approximately $5.0 million, which includes the full exercise of the underwriter’s over-allotment option to purchase additional shares and warrants.
ARLINGTON, Va., June 10, 2025 /PRNewswire/ -- A new survey conducted by Instrument Business Outlook (IBO) has uncovered significant reductions in laboratory budgets across the...
CALGARY, AB, June 10, 2025 (GLOBE NEWSWIRE) -- The Alberta Energy Regulator (AER) has released its 2024 Pipeline Performance Report, the latest in its annual series tracking industry performance on pipeline safety across the province.